Acadia Pharmaceuticals (ACAD) EBITDA Margin (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted EBITDA Margin of 12.29% for Q2 2026, up 813.48% on a QoQ basis from 1.72% in Q1 2026, and up 5.0% year-over-year from 11.7% in Q2 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) EBITDA Margin (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals has reported EBITDA Margin for 17 years, with the latest figure at 12.29% in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 5.0% year-over-year to 12.29% in Q2 2026; TTM through Jun 2026 was 7.59%, a 1566.0% decrease from a year earlier, with the FY2025 full-year figure at 9.78%, down 1431.0% from the prior year.
- EBITDA Margin was 12.29% for Q2 2026 at Acadia Pharmaceuticals, up from 1.72% in the prior quarter.
- The five-year high for EBITDA Margin was 59.13% in Q4 2024, with the low at 97.88% in Q1 2022.
- Average EBITDA Margin over 5 years is 5.25%, with a median of 6.76% recorded in 2025.
- The sharpest annual moves came in 2023 and 2025: EBITDA Margin jumped 5264 bps in 2023, then sank 5301 bps in 2025.
- Over 5 years, EBITDA Margin stood at 33.75% in 2022, then soared by 145 bps to 15.12% in 2023, then jumped by 291 bps to 59.13% in 2024, then sank by 90 bps to 6.12% in 2025, then surged by 101 bps to 12.29% in 2026.
- The last three EBITDA Margin figures came in at 12.29% (Q2 2026), 1.72% (Q1 2026), and 6.12% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 37.40% |
| 10 | Acadia Pharmaceuticals | 4.38 Bn | 3.42 Bn | 279.64 Mn | 12.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.29% |
| Mar 31, 2026 | -1.72% |
| Dec 31, 2025 | 6.12% |
| Sep 30, 2025 | 12.83% |
| Jun 30, 2025 | 12.24% |
| Mar 31, 2025 | 7.90% |
| Dec 31, 2024 | 59.13% |
| Sep 30, 2024 | 12.64% |
| Jun 30, 2024 | 12.58% |
| Mar 31, 2024 | 7.39% |
| Dec 31, 2023 | 15.12% |
| Sep 30, 2023 | -27.29% |
| Jun 30, 2023 | 1.84% |
| Mar 31, 2023 | -45.23% |
| Dec 31, 2022 | -33.75% |
| Sep 30, 2022 | -23.61% |
| Jun 30, 2022 | -25.01% |
| Mar 31, 2022 | -97.88% |
| Dec 31, 2021 | -34.15% |
| Sep 30, 2021 | -11.63% |
API Access
Acadia Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();